Clinical Study of ShuangPiZhuoYu prescription in the Treatment of Rosacea
- Conditions
- rosacea
- Registration Number
- ITMCTR2022000093
- Lead Sponsor
- Xiyuan Hospital, Chinese Academy of traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
(1) Patients with rosacea erythematous telangiectasia and papular pustule according to Western medical diagnostic criteria;
(2) The patients who were diagnosed by two dermatologists or above and meet the clinical diagnosis of roseacea toxin heat stasis syndrome;
(3) 18-65 years old, male or female;
(4) The patients signed the informed consent, voluntarily participated in the study, complied with the study protocol, insisted on medication, and returned to the clinic on time.
(1) Patients with other facial skin diseases, such as hormone dependent dermatitis;
(2) The use of drugs in recent 2 weeks may affect the test results;
(3) Pregnant or lactating women;
(4) Have serious various diseases of primary systems;
(5) Patients with other skin diseases requiring treatment;
(6) Those who are allergic to therapeutic drugs;
(7) Those who participate in other clinical trials at the same time.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Symptom index and score;Efficacy evaluation;
- Secondary Outcome Measures
Name Time Method dermatology life quality index;Inflammatory factors assay;